HighTower Trust’s Biogen BIIB Stock Holding History

HighTower Trust’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$385K	Hold	1,500	–	–	0.04%	169
2022 Q4	$411K	Sell	1,500 -15	-1%	-$4.24K	0.04%	161
2022 Q3	$405K	Buy	+1,515	New	+$322K	0.04%	154
2022 Q2	–	Sell	-1,518	Closed	-$320K	–	236
2022 Q1	$320K	Buy	1,518 +18	+1%	+$3.91K	0.03%	189
2021 Q4	$360K	Buy	+1,500	New	+$386K	0.04%	179
2018 Q4	–	Sell	-13,735	Closed	-$4.85M	–	103
2018 Q3	$4.85M	Hold	13,735	–	–	0.54%	32
2018 Q2	$3.99M	Hold	13,735	–	–	0.46%	34
2018 Q1	$3.76M	Sell	13,735 -510	-4%	-$158K	0.46%	33
2017 Q4	$4.54M	Hold	14,245	–	–	0.51%	33
2017 Q3	$4.46M	Hold	14,245	–	–	0.53%	33
2017 Q2	$3.87M	Buy	14,245 +1,230	+9%	+$325K	0.44%	37
2017 Q1	$3.56M	Buy	13,015 +5	+0%	+$1.41K	0.41%	39
2016 Q4	$3.69M	Buy	13,010 +740	+6%	+$219K	0.41%	37
2016 Q3	$3.84M	Buy	12,270 +510	+4%	+$151K	0.43%	34
2016 Q2	$2.84M	Buy	11,760 +2,040	+21%	+$538K	0.3%	44
2016 Q1	$2.53M	Buy	9,720 +2,040	+27%	+$539K	0.32%	42
2015 Q4	$2.35M	Buy	+7,680	New	+$2.21M	0.32%	37

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HighTower Trust's BIIB Position: Q1 2023 in Review

HighTower Trust held its Biogen (BIIB) position steady in Q1 2023 at 1,500 shares worth $385K. The position accounts for 0.04% of the portfolio, ranked #169.

HighTower Trust first reported a position in BIIB in Q4 2015 and has held it in 17 quarters since. The position peaked at $4.85M in Q3 2018. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.

HighTower Trust held 1,500 shares of Biogen worth $385K as of Q1 2023.
HighTower Trust left its Biogen share count unchanged in Q1 2023.
Biogen made up 0.04% of HighTower Trust's portfolio in Q1 2023, its #169 holding.
HighTower Trust first reported a position in Biogen in Q4 2015 and has held it in 17 quarters since.
HighTower Trust's Biogen position peaked at $4.85M in Q3 2018.
1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2023.

Based on HighTower Trust's 13F filing for Q1 2023, filed 21 Apr 2023.